9G8 Activators
9G8 Activators play a pivotal role in modulating the activity of 9G8, a protein integral to RNA splicing, through various indirect mechanisms. Compounds such as SRPIN340 and Cdc2-Like Kinase Inhibitor, TG003, which inhibit serine/arginine-rich protein kinases (SRPKs) and Cdc2-like kinases (CLKs) respectively, indirectly enhance 9G8 activity by altering the phosphorylation status of SR proteins. This reduced phosphorylation leads to changes in splicing patterns, potentially augmenting the involvement of 9G8 in specific splicing events. Similarly, KH CB19 contributes to this modulation by directly impacting the kinases responsible for SR protein phosphorylation. This cascade of alterations in phosphorylation dynamics indirectly shifts splicing factor activities, favoring 9G8-mediated splicing events.
Furthermore, diverse molecules like Heparin, Dibutyryl-cAMP, Amiloride, Sodium Salicylate, and Ellagic Acid, Dihydrate indirectly influence 9G8 activity through their effects on cellular signaling pathways and interactions with SR proteins. These interactions and signaling modifications can lead to changes in the functional dynamics of splicing factors, indirectly enhancing the role of 9G8 in RNA processing. Additionally, compounds such as Pladienolide B, a spliceosome inhibitor, and Trichostatin A, a histone deacetylase inhibitor, further influence the splicing landscape, potentially increasing the functional involvement of 9G8 in RNA splicing. Anisomycin, by affecting stress response pathways, and inhibitors targeting Protein Kinase C, also contribute to this complex regulatory network. These activators, through their varied actions, underscore the intricate and multifaceted mechanisms that regulate the activity of 9G8, highlighting its critical role in the post-transcriptional regulation of gene expression and the maintenance of cellular function.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Cdc2-Like Kinase Inhibitor, TG003 | 300801-52-9 | sc-202528 sc-202528A | 5 mg 25 mg | $139.00 $548.00 | 6 | |
Cdc2-Like Kinase Inhibitor, TG003, a CLK1/CLK4 inhibitor, indirectly enhances 9G8 activity by modulating the phosphorylation status of SR proteins. Reduced CLK activity leads to changes in splicing patterns, potentially favoring 9G8-mediated splicing events. | ||||||
Heparin | 9005-49-6 | sc-507344 | 25 mg | $119.00 | 1 | |
Heparin, while primarily known as an anticoagulant, can indirectly enhance 9G8 activity. It interacts with SR proteins and can influence splicing factor dynamics, potentially increasing 9G8's role in RNA splicing. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
Dibutyryl-cAMP, a cAMP analog, indirectly enhances 9G8 activity by influencing cellular signaling pathways. This can lead to changes in the phosphorylation of SR proteins, indirectly affecting 9G8's splicing activity. | ||||||
Amiloride | 2609-46-3 | sc-337527 | 1 g | $296.00 | 7 | |
Amiloride can indirectly enhance 9G8 activity. It affects intracellular signaling and ion transport, which can influence SR protein function and potentially increase 9G8's role in RNA processing. | ||||||
Sodium Salicylate | 54-21-7 | sc-3520 sc-3520A sc-3520B sc-3520C | 1 g 25 g 500 g 1 kg | $10.00 $26.00 $82.00 $139.00 | 8 | |
Sodium Salicylate, an anti-inflammatory agent, can indirectly influence 9G8 activity. It modulates cellular signaling pathways that may affect SR protein function, potentially enhancing 9G8's involvement in splicing. | ||||||
Pladienolide B | 445493-23-2 | sc-391691 sc-391691B sc-391691A sc-391691C sc-391691D sc-391691E | 0.5 mg 10 mg 20 mg 50 mg 100 mg 5 mg | $299.00 $5699.00 $11099.00 $25500.00 $66300.00 $2875.00 | 63 | |
Pladienolide B, a splicing inhibitor, indirectly influences 9G8 activity by targeting the spliceosome. Its action can lead to altered splicing factor dynamics, potentially increasing the functional involvement of 9G8 in RNA splicing. | ||||||
Ellagic Acid, Dihydrate | 476-66-4 | sc-202598 sc-202598A sc-202598B sc-202598C | 500 mg 5 g 25 g 100 g | $58.00 $95.00 $245.00 $727.00 | 8 | |
Ellagic Acid, Dihydrate, a natural phenol, indirectly enhances 9G8 activity. It can influence cellular signaling and SR protein dynamics, potentially affecting 9G8's role in the regulation of alternative splicing. | ||||||
Calphostin C | 121263-19-2 | sc-3545 sc-3545A | 100 µg 1 mg | $343.00 $1642.00 | 20 | |
This inhibitor, targeting Protein Kinase C, indirectly enhances 9G8 activity by influencing the phosphorylation status of SR proteins. Altered PKC activity can lead to changes in splicing patterns, favoring 9G8-mediated events. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin, a protein synthesis inhibitor, can indirectly enhance 9G8 activity. By influencing stress response pathways, it may affect SR protein function and potentially increase 9G8's involvement in splicing. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A, a histone deacetylase inhibitor, indirectly influences 9G8 activity. By altering chromatin structure and gene expression, it can affect the dynamics of splicing factors, potentially enhancing 9G8's role in RNA processing. | ||||||